SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : Rat dog micro-cap picks...

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Bucky Katt who wrote (6146)10/19/2001 6:13:18 PM
From: christopher  Read Replies (4) of 48461
 
Yup, I was thinking if some big names or organizations start taking a hard look at stun guns TASR/W could really make a move....well now I'm seeing why ICCC is moving....

Message 16510621

ImmuCell Up 15%; Product May Help Fight On Anthrax: CEO
Updated: Friday, October 19, 2001 12:39 PM ET  
 

By Frank Byrt

Of DOW JONES NEWSWIRES

BOSTON (Dow Jones)--Shares of ImmuCell Corp. (ICCC, news, msgs) were up Friday after news reports that the one of the company's animal care products may have the potential to kill anthrax bacteria.

Shares of ImmuCell, which has a market capitalization of $14.4 million, recently rose 13.1%, or 57 cents, to $4.93 on volume of 326,300 compared with average daily volume of 8,500.

 Stock Insight

 Symbol Last Change

 ICCC 4.7400 +0.3800 

 Index

 Dow Jones 9204.11 +40.89 

 NASDAQ 1671.31 +18.59 

 
 More Analysis
•  See Analyst Ratings
•  Compare Growth Trends
•  Get One-Click Scorecard
   

Shares reached a 52-week high of $5.20 Thursday; they have been as low as $1.50 on Dec. 27.

Michael Brigham, chief executive officer of the Portland, Maine, company said a local press report about the company's effort to bring the government's attention to the anthrax fighting potential of its "Wipe Out" cleansing products for dairy cows "definitely" appears to be the cause of the share price rise.

ImmuCell contacted U.S. Sen. Olympia Snowe, R-Maine, this week to bring to her attention the possible anthrax-fighting potential of Wipe Out, he said, so should could alert the proper government officials.

That prompted the media interest.

But he government has not contacted the company to follow up. "We hope to work with them, but there's nothing active or formal," Brigham said.

The active ingredient in the Wipe Out cloths is Nisin, which has been proven to be effective in killing a broad array of bacteria including Bacillus, a genus that also includes anthrax, Brigham said.

The company thinks it may be worth testing it for applications in fighting anthrax.

"There is a fair amount of literature that shows the effectiveness of Nisin in killing Bacillus," he said, and so if it indeed proves effective against anthrax, it might find a place in mail rooms as a hand wipe.

The company acquired the rights to Wipe Out in December, 1999, Brigham said, and it has been a popular seller to dairy farmers, who wipe cows' udders with the product before milking in order to cleanse them.

Brigham said his company isn't aware of any sales of Wipe Out that can be attributed to the reports of its anthrax-fighting potential.

The firm primarily develops of biotechnology products for the dairy industry.

No analysts cover the company, Brigham said.

Annual sales at the company is about $6 million, Brigham said.

-Frank Byrt, Dow Jones Newswires; 617-654-6742; frank.byrt@dowjones.com

Sen. Snowe's office in Portland, Maine, confirmed that she was contacted by ImmuCell about its animal care product's potential in killing anthrax. That information was passed along to the Department of Defense and to U.S. Sen. John Warner, R-Va., who is a member of the Senate Armed Services Committee, said Davis Lackey, communications director for Snowe.

ImmuCell is following through with those contacts, he said.

-Frank Byrt, Dow Jones Newswires; 617-654-6742; frank.byrt@dowjones.com

 
Subscribe to free
Quicken.com newsletters!

 
Get Quotes & Research
 Enter symbol(s):
  Go
 Don't know the symbol?

Latest ICCC Headlines
 
•  ImmuCell In Option To Sell Lactoferrin Venture Stake Dow Jones, August 6, 2001
 
•  ImmuCell Enters Into Option to Sell Its Interest in Lactofe... Business Wire, August 6, 2001
 
•  ImmuCell 2nd Quarter Net 4 Cents/Share Dow Jones, July 23, 2001
 
•  ImmuCell 2Q Net 4c/Shr Dow Jones, July 23, 2001
 
•  ImmuCell Announces Continued Profits With 24% Quarterly and 13% Year-to-date... Business Wire, July 23, 2001
 
More ICCC News
 
 
More News
•  My Portfolio News
•  U.S. Market News
•  Top Business News
•  Analyst News
•  IPO News

------------------------------------------------------------------------
site stuff   Sign Out · Edit Profile · Help Center · Free Newsletters
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext